HER2-targeted therapies

HER2-targeted therapies are medications designed to specifically attack cancer cells that have an excess of a protein called HER2, which promotes tumor growth. By targeting this protein, these therapies help stop the cancer from growing and spreading. Examples include drugs like trastuzumab and pertuzumab, which can be used alone or with chemotherapy. They are effective in treating HER2-positive breast cancers and other HER2-related cancers, improving outcomes and survival rates. These therapies work by blocking HER2 signals or marking cancer cells for destruction by the immune system, offering a focused approach with fewer side effects than traditional treatments.